Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
ARCT compared with NTLA: revenue, margins and what each company keeps, and the suppliers and customers both name
ARCT
Arcturus Therapeutics Holdings Inc.
Change
Mkt cap
Revenue
Revenue
NTLA
Intellia Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
ARCT
Arcturus Therapeutics Holdings Inc.
vs
NTLA
Intellia Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
ARCT: latest quarter is a loss; flow not drawable. NTLA: latest quarter is a loss; flow not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only ARCT
3
—
Biomedical Advanced Research and Development Authority (BARDA)
unlisted
customer
—
CSL Seqirus
unlisted
customer
—
Meiji Seika Pharma
unlisted
customer
Shared
0
No shared counterparties.
Only NTLA
4
REGN
Regeneron Pharmaceuticals
customer
CRBU
Caribou Biosciences
supplier
—
AvenCell Therapeutics
unlisted
customer
—
SparingVision SAS
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
unlisted
customer
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
ARCT, solid
NTLA, dashed
ARCT
Arcturus Therapeutics Holdings Inc.
Change
9.54
· pre 9.54
· delayed
Mkt cap
$271.2M
Revenue
$3M
Q2 FY26
Revenue
$82M
FY25
NTLA
Intellia Therapeutics, Inc.
Change
11.86
· pre 11.90
· delayed
Pre-market
Nov 3 '26
delayed
Mkt cap
$1.6B
Revenue
$8M
Q2 FY26
Revenue
$68M
FY25
vs
Compare
Pre-market
Nov 3 '26
delayed
ARCT
Arcturus Therapeutics Holdings Inc.
vs
NTLA
Intellia Therapeutics, Inc.
9.54
pre 9.54
delayed
Price
11.86
pre 11.90
delayed
$271.2M
Mkt cap
$1.6B
Q2 FY26
$3M
Revenue
$8M
Q2 FY26
FY25
$82M
Revenue
$68M
FY25
Change
Change
ARCT
9.54
vs
NTLA
11.86
Pre-market
Nov 3 '26
delayed